De Novo device
Coaptium Connect with Tissium Light
Tissium SA · In Situ Polymerizing Peripheral Nerve Repair Device (SFD, Class II) · First FDA decision Jun 17, 2025, newest Sep 8, 2025Peripheral neuropathy and nerve injury
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
De Novo pathway
Device trials
1
Naming "Coaptium Connect"
MAUDE reports
2
Brand "Coaptium Connect", since 2015
PubMed studies
1
Mentioning "Coaptium Connect"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Coaptium Connect with Tissium Light
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
K251957 · Decided Sep 8, 2025 · 75 days after receipt
Device type: In Situ Polymerizing Peripheral Nerve Repair Device (SFD) · Neurology & Neurosurgery
- COAPTIUM Connect with TISSIUM LIGHTNew device typeDe Novo
DEN240066 · Decided Jun 17, 2025 · 208 days after receipt
Device type: In Situ Polymerizing Peripheral Nerve Repair Device (SFD) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Peripheral Nerve Injections and Procedures for Chronic PainLocal determinationIn effectL40265Noridian Healthcare Solutions, LLCUpdated Oct 15, 2026
- Peripheral Nerve Injections and Procedures for Chronic PainLocal determinationIn effectL40300WPS Insurance CorporationUpdated Oct 15, 2026
- Peripheral Nerve Injections and Procedures for Chronic PainLocal determinationIn effectL40267Wellpoint FederalUpdated Oct 14, 2026
- Peripheral Nerve Injections and Procedures for Chronic PainLocal determinationIn effectL40261CGS Administrators, LLCUpdated Oct 12, 2026
- Peripheral Nerve Injections and Procedures for Chronic PainLocal determinationIn effectL40263Palmetto GBAUpdated Oct 12, 2026
- Nerve Blocks for Peripheral NeuropathyLocal determinationIn effectL35249CGS Administrators, LLCUpdated Apr 29, 2026
- Peripheral Nerve StimulationLocal determinationIn effectL34328Noridian Healthcare Solutions, LLCUpdated Oct 14, 2025
- Peripheral Nerve Blocks and Procedures for Chronic PainProposed local determinationProposedDL40263Palmetto GBAUpdated Sep 19, 2025
Clinical trials
Device studies on ClinicalTrials.gov that name "Coaptium Connect", any status and sponsor, newest update first.
- SECURE Post-Market StudyNot yet recruiting
TissiumNot on our public-company list
NCT07756489 · 65 participants (planned) · Start Oct 2026 · Primary completion Apr 2028
Device: COAPTIUM® CONNECT · For: Digital Nerve Injury
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Coaptium Connect", and for the whole product code for context.
This brand
2 reports: 1 malfunction, 1 injury, 0 death
Whole product code SFD
2 reports: 1 malfunction, 1 injury, 0 death
Newest reports for this brand
3021453307-2026-00002 · Received Mar 26, 2026 · Event dated Feb 26, 2026
Device type: In Situ Polymerizing Peripheral Nerve Repair Device (SFD)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Wound Dehiscence
- COAPTIUM CONNECTMalfunction
3021453307-2026-00001 · Received Feb 24, 2026 · Event dated Jan 28, 2026
Device type: In Situ Polymerizing Peripheral Nerve Repair Device (SFD)
Device problem as coded: Fracture; Material Integrity Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Coaptium Connect"[tiab]. The summary above synthesizes these.
- A Sutureless Approach to Nerve Repair: Results From a Clinical Study in Digital Nerves.
Bindra R, Wagels M, Brett ME, et al. · J Hand Surg Glob Online · 2026
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.